Spear Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-37,681
Closed -$34.7M 20
2026
Q1
$34.7M Buy
+37,681
New +$38.2M 3.46% 13
2025
Q4
Sell
-45,390
Closed -$34.6M 17
2025
Q3
$34.6M Sell
45,390
-7,810
-15% -$5.81M 1.95% 17
2025
Q2
$41.5M Buy
+53,200
New +$41.3M 3.04% 15

Other funds holding LLY

Spear Holdings's LLY Position: Q2 2026 in Review

Spear Holdings sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 37,681 shares — an estimated $34.7M sold.

Spear Holdings first reported a position in LLY in Q2 2025 and held it in 3 quarters. The position peaked at $41.5M in Q2 2025. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Spear Holdings reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Spear Holdings sold 37,681 Eli Lilly shares in Q2 2026, an estimated $34.7M.
  • Spear Holdings first reported a position in Eli Lilly in Q2 2025 and held it in 3 quarters.
  • Spear Holdings's Eli Lilly position peaked at $41.5M in Q2 2025.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Spear Holdings's 13F filing for Q2 2026, filed 27 Jul 2026.